Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NKTR

Nektar

$72.00

2.12 (3.03%)

05:45
01/16/18
01/16
05:45
01/16/18
05:45
Recommendations
Nektar analyst commentary at Jefferies »

Nektar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

Monday
SHPG

Shire

$147.55

-0.86 (-0.58%)

, NKTR

Nektar

$72.00

2.12 (3.03%)

13:34
01/15/18
01/15
13:34
01/15/18
13:34
Hot Stocks
Shire granted Marketing Authorization for Adynovi in Europe »

Shire plc (SHPG)…

SHPG

Shire

$147.55

-0.86 (-0.58%)

NKTR

Nektar

$72.00

2.12 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 25

    Mar

Over a week ago
NKTR

Nektar

$68.03

10.63 (18.52%)

10:24
01/10/18
01/10
10:24
01/10/18
10:24
Recommendations
Nektar analyst commentary at Canaccord »

Nektar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

NKTR

Nektar

$57.40

-0.36 (-0.62%)

, INCY

Incyte

$100.81

0.96 (0.96%)

15:32
01/09/18
01/09
15:32
01/09/18
15:32
Hot Stocks
Feuerstein sees 'irrational exuberance' over Nektar tumor drug »

STAT's Adam…

NKTR

Nektar

$57.40

-0.36 (-0.62%)

INCY

Incyte

$100.81

0.96 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 18

    Jan

  • 26

    Feb

NKTR

Nektar

$57.40

-0.36 (-0.62%)

15:13
01/09/18
01/09
15:13
01/09/18
15:13
Hot Stocks
Nektar sees NKTR-262 Phase 1 dosing in Q1, NKTR-181 NDA in Q2 »

Nektar President and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 26

    Feb

Over a month ago
NKTR

Nektar

$55.05

-1.58 (-2.79%)

, BAYRY

Bayer

$30.94

-0.405 (-1.29%)

08:53
12/15/17
12/15
08:53
12/15/17
08:53
Hot Stocks
Bayer terminates development and license agreement with Nektar »

Nektar Therapeutics…

NKTR

Nektar

$55.05

-1.58 (-2.79%)

BAYRY

Bayer

$30.94

-0.405 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

T

AT&T

$38.04

-0.06 (-0.16%)

, TWX

Time Warner

$90.06

-0.59 (-0.65%)

07:35
12/14/17
12/14
07:35
12/14/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

T

AT&T

$38.04

-0.06 (-0.16%)

TWX

Time Warner

$90.06

-0.59 (-0.65%)

EA

Electronic Arts

$105.54

-2.12 (-1.97%)

MRO

Marathon Oil

$15.20

0.02 (0.13%)

UNP

Union Pacific

$130.31

-0.39 (-0.30%)

MO

Altria Group

$72.32

0.6 (0.84%)

OCLR

Oclaro

$7.50

0.43 (6.08%)

VIPS

Vipshop

$8.42

0.24 (2.93%)

DDD

3D Systems

$9.89

0.38 (4.00%)

NKTR

Nektar

$56.63

1.76 (3.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 15

    Feb

NKTR

Nektar

$54.87

-0.34 (-0.62%)

13:40
12/13/17
12/13
13:40
12/13/17
13:40
Options
Notable call buying in Nektar as shares reach 52-week highs »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$54.87

-0.34 (-0.62%)

08:54
12/13/17
12/13
08:54
12/13/17
08:54
Hot Stocks
Nektar to pay Daiichi Sankyo $12.5M for collaboration termination »

Nektar Therapeutics last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$52.59

2.84 (5.71%)

12:35
11/27/17
11/27
12:35
11/27/17
12:35
Options
Nektar put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.